Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sarah K Emond"'
Autor:
Steven D Pearson, Prabhjot Singh, Francesca Beaudoin, Jon Campbell, Lindsey Schapiro, Sarah K Emond, Caroline Pearson
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 12 (2023)
Digital health technologies (DHTs) are a broad and rapidly innovating class of interventions with distinctive pathways for development, regulatory approval, uptake and reimbursement. Given the unique nature of DHTs, existing value assessment framew
Externí odkaz:
https://doaj.org/article/4cc8fc592c4d48c7b0a6e8facae7f7d1
Autor:
Robert W. Dubois, J. Lee Hargraves, Olubode A. Olufajo, Sarah K. Emond, Joel S. Weissman, Steven D. Pearson, Kimberly Westrich
Publikováno v:
Journal of Comparative Effectiveness Research. 4:79-88
Background: As the USA seeks to expand the conduct and dissemination of comparative effectiveness research (CER), views of key stakeholders will help guide the way. Methods: We surveyed 60 medical and pharmacy directors from 46 state Medicaid program
Publikováno v:
Journal of Women's Health & Gender-Based Medicine. 10:343-350
Postmenopausal women who choose hormone replacement therapy (HRT) often discontinue this therapy within 1 year. Few studies have considered why older women (agedor =65 years) discontinue therapy. To investigate this question and its relationship to H
Publikováno v:
Journal of Clinical Densitometry. 4:373-380
The presence of a vertebral fracture significantly increases the risk of future fracture, classifies a patient with “clinical” osteoporosis, and usually results in treatment for osteoporosis. However, the majority of vertebral fractures are silen
Publikováno v:
Postgraduate medicine. 125(6)
Treatment-resistant depression (TRD) is a debilitating patient condition with significant clinical and economic impact. The introduction of a new treatment approach, repetitive transcranial magnetic stimulation (rTMS), created the opportunity for a m
Publikováno v:
Postgraduate medicine. 124(5)
Parents, clinicians, and policymakers require the latest evidence to help inform treatment decisions. The New England Comparative Effectiveness Public Advisory Council (CEPAC) leverages existing federally produced comparative effectiveness research s